BIM — Biomerieux SA Cashflow Statement
0.000.00%
Last trade - 00:00
- €12.36bn
- €12.53bn
- €3.67bn
- 97
- 11
- 68
- 63
2019 December 31st | 2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 270 | 403 | 598 | 441 | 323 |
Depreciation | |||||
Non-Cash Items | 45.5 | 159 | 177 | 265 | 414 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -96.8 | -190 | -9 | -297 | -291 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 408 | 583 | 825 | 475 | 445 |
Capital Expenditures | -273 | -278 | -290 | -287 | -338 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -9.7 | 12.3 | -17.2 | -241 | -151 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Cash from Investing Activities | -282 | -265 | -307 | -528 | -489 |
Financing Cash Flow Items | -23.4 | -2.4 | — | -0.1 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -134 | -176 | -141 | -244 | -122 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -14.3 | 107 | 416 | -259 | -195 |